A. Kolte, Hoshiar Mal, Mugdha Fulambrikar, A. Jagtap
{"title":"Impact of price control on pharmaceutical sector with reference to India","authors":"A. Kolte, Hoshiar Mal, Mugdha Fulambrikar, A. Jagtap","doi":"10.1504/ijie.2021.10034446","DOIUrl":null,"url":null,"abstract":"In India, drug prices are controlled and are commonly known as Drug Price Control Orders (DPCO) issued under the Indian Essential Commodities Act of 1955. It is governed by the National Pharmaceutical Pricing Policy (NPPP) and accordingly, a National List for Essential Medicines (NLEM) was formulated. DPCO is useful for controlling the prices of life-saving drugs that are essential in the current scenario of healthcare and diseases. All the essential drugs are included under DPCO and a ceiling price is formulated. Drug prices cannot exceed the limit stipulated by DPCO. We have studied DPCO and discussed its impact on the pharmaceutical sector. The paper encompasses the brief history of DPCO, its contents, objectives, etc. Effects of DPCO on foreign trade is also analysed in this paper. We have attempted to find the effects of drug price control and its implications on the industry as a whole. We have also attempted to gaze future prospects for the pharmaceutical industry.","PeriodicalId":39490,"journal":{"name":"International Journal of Intelligent Enterprise","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Intelligent Enterprise","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1504/ijie.2021.10034446","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Business, Management and Accounting","Score":null,"Total":0}
引用次数: 3
Abstract
In India, drug prices are controlled and are commonly known as Drug Price Control Orders (DPCO) issued under the Indian Essential Commodities Act of 1955. It is governed by the National Pharmaceutical Pricing Policy (NPPP) and accordingly, a National List for Essential Medicines (NLEM) was formulated. DPCO is useful for controlling the prices of life-saving drugs that are essential in the current scenario of healthcare and diseases. All the essential drugs are included under DPCO and a ceiling price is formulated. Drug prices cannot exceed the limit stipulated by DPCO. We have studied DPCO and discussed its impact on the pharmaceutical sector. The paper encompasses the brief history of DPCO, its contents, objectives, etc. Effects of DPCO on foreign trade is also analysed in this paper. We have attempted to find the effects of drug price control and its implications on the industry as a whole. We have also attempted to gaze future prospects for the pharmaceutical industry.
期刊介绍：
Major catalysts such as deregulation, global competition, technological breakthroughs, changing customer expectations, structural changes, excess capacity, environmental concerns and less protectionism, among others, are reshaping the landscape of corporations worldwide. The assumptions about predictability, stability, and clear boundaries are becoming less valid as two factors, by no means exhaustive, have a clear impact on the nature of the competitive space and are changing the sources of competitive advantage of firms and industries in new and unpredictable ways: agents with knowledge and interactions.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
